These include: Severe headaches , particularly if sudden-onset or different from usual patterns Visual disturbances such as blurred vision or seeing spots Chest pain or pressure , which may indicate cardiovascular complications (call 911) Shortness of breath or difficulty breathing, especially with exertion (call 911 if severe) Neurological symptoms including facial drooping, arm weakness, speech difficulties (call 911) Severe dizziness or lightheadedness , particularly upon standing (suggesting hypotension) Nosebleeds that are difficult to control Confusion or difficulty concentrating Patients should also promptly report semaglutide-specific concerns that may require immediate evaluation: Severe, persistent abdominal pain (possible pancreatitis) Right upper quadrant pain, fever, or yellowing of skin/eyes (possible gallbladder disease) Signs of allergic reaction including rash, swelling, or difficulty breathing New or worsening vision problems (potential diabetic retinopathy complications) Persistent nausea, vomiting, or diarrhea can lead to dehydration, electrolyte imbalances, and secondary blood pressure changes

Research has demonstrated that obesity is associated with increased risk of type 2 diabetes, heart disease, stroke, sleep apnea, hypertension, and certain cancers
It says the provider should assess these and set a ceiling aligned with tolerability and clinical goals
A prescription is required for both brand-name and compounded semaglutide
Temperature Matters Injecting medication at the proper temperature can relieve pain
Those numbers represent the successful operation of a policy framework designed to balance innovation rewards with competitive access and they explain why Hatch-Waxman remains the most consequential piece of pharmaceutical market legislation ever enacted